Delivery Order SPE2DB20D3103-SPE2DB25FM8K2
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,699.97, is for the delivery of 2 mg vials of the drug Remifentanil. The contract has a period of performance through May 24, 2024 and utilizes a Firm Fixed Price pricing type. This Delivery Order is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Remifentanil 2 mg vials. The $1,836.39 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,470.33, is for the delivery of REMIFENTANIL 2 MG VIALS, a specialty medication. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,881.58, is a Firm Fixed Price Delivery Order for the supply of 2 mg vials of the drug Remifentanil. The contract has a period of performance through January 29, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Remifentanil 2 mg vials. The $4,848.64 firm-fixed-price contract has a completion date of September 15, 2021. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of REMIFENTANIL 1 MG VIALS. The $2,686.05 firm-fixed-price delivery order has a completion date of December 6, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award is for the delivery of 2 mg vials of the drug remifentanil, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $2,909.03 fixed-price delivery order is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Remifentanil 1 mg vials, a specialty medication. The fixed-price delivery order has a ceiling value of $3,632.56 and a completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,373.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), which is valued at $999,999,999 and runs through November 2026. The contract is for the delivery of 4563335062 - REMIFENTANIL 2 MG VIALS, a critical pharmaceutical product used in various...
This contract award, SPE2DB22D2206|SPE2DB24FEG06, is a delivery order valued at $2,442.40 for the supply of 1 mg vials of the pharmaceutical drug remifentanil. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract does not have a set-aside designation, indicating it was open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...